{"name":"Pipradrol","slug":"pipradrol","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Pipralon","Piridrol","Pyridrol","Pyridrole","Pipradol","α-Pipradol","Gerodyl","Pipradrolum","Pipradrolo","α-(2-Piperidyl)benzhydrol"],"brands":[],"scraped":true,"has_structure":true,"cid":10083,"classes":[{"name":"stimulant","href":"/class/stimulant"}],"families":[{"name":"2-benzylpiperidine","href":"/substituted/2-benzylpiperidine"}],"physical":[{"label":"Molecular mass","value":"267.40 g/mol","copyable":false},{"label":"Appearance","value":"Crystals from hexane","copyable":false},{"label":"Melting point","value":"97.5 °C","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits toxic fumes of /nitrogen oxides/.","copyable":false},{"label":"Predicted LogP","value":"3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>18</sub>H<sub>21</sub>NO","copyable":true},{"label":"IUPAC name","value":"diphenyl(piperidin-2-yl)methanol","copyable":true},{"label":"SMILES","value":"C1CCNC(C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)O","copyable":true},{"label":"InChI","value":"InChI=1S/C18H21NO/c20-18(15-9-3-1-4-10-15,16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17,19-20H,7-8,13-14H2","copyable":true},{"label":"InChIKey","value":"XSWHNYGMWWVAIE-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"467-60-7","copyable":true},{"label":"UNII","value":"S6I030E0DA","copyable":true},{"label":"PubChem CID","value":"10083","copyable":true}],"pharmacokinetics":[],"toxicity":[{"kind":"LD50","organisms":[["Cat",[{"kind":"LD50","organism":"Cat","route":"iv","dose":"15 mg/kg"}]],["Mouse",[{"kind":"LD50","organism":"Mouse","route":"ip","dose":"74 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"oral","dose":"74 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"180 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N06","description":"Psychoanaleptics"},{"code":"N06B","description":"Psychostimulants, agents used for adhd and nootropics"},{"code":"N06BX","description":"Other psychostimulants and nootropics"},{"code":"N06BX15","description":"Pipradrol"}],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Pipradrol and pipradrol derivatives are norepinephrine and dopamine reuptake inhibitors.    In a pharmacokinetic study, it was shown that pipradrol conditioned place preference (CPP) was blocked by selective D1 dopamine antagonist, implicating that a rewarding effect of pipradrol may involve the activation of D1 dopamine receptors.  Pipradrol has a definite cerebral stimulating effect without affecting the blood pressure or respiration and has been used to counteract post-anaesthetic and chlorpromazine depression in man. Structurally related to phenylmethylamphetamine, a potent stimulant with a long half-life, pipradrol differs from amphetamine in that its action is more intense at higher centers, it does not exhibit pressor activity, there is no post-excitement depression, and this drug does not decrease appetite, as occurs with amphetamine.","side_effects":null,"effects":{"groups":[["Physical Effects",["Abnormal heartbeat","Appetite suppression","Dehydration","Dry mouth","Increased blood pressure","Increased heart rate","Increased libido","Restless legs","Shakiness","Stamina enhancement","Stimulation","Teeth grinding","Vasoconstriction"]],["Cognitive Effects",["Analysis enhancement","Cognitive euphoria","Compulsive redosing","Disinhibition","Ego inflation","Focus enhancement","Increased music appreciation","Mania","Motivation enhancement","Suggestibility suppression","Thought acceleration","Wakefulness"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Anlage III","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"New Zealand","status":"Class C","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Class C","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"United Nations","status":"Psychotropic Schedule IV","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Pipradrol"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/10083"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q2084598"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB11584"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2110938"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A135101"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=467-60-7"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID2023486"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Pipradrol"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/S6I030E0DA"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 10083, Pipradrol. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/10083>https://pubchem.ncbi.nlm.nih.gov/compound/10083</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pipradrol. UNII: S6I030E0DA. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S6I030E0DA>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S6I030E0DA</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 10:02:08","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 10:02:04","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 10:02:04","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 10:02:04","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 10:02:04","note":"no HMDB id"},{"source":"kegg","status":"missing","fetched_at":"2026-11-20 10:02:08","note":"no KEGG DRUG entry"},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 10:02:03","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 10:02:04","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 10:02:04","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 10:02:04","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 10:02:04","note":null}],"description":"Pipradrol is a stimulant substance."}